SWM
TMO icon

Silverlake Wealth Management’s Thermo Fisher Scientific TMO Stock Holding History

Silverlake Wealth Management’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-633
Closed -$392K – 288
2024
Q3 		$392K Sell
633
-34
-5% -$20.1K 0.15% 168
2024
Q2 		$369K Sell
667
-4
-0.6% -$2.29K 0.15% 169
2024
Q1 		$390K Sell
671
-3
-0.4% -$1.68K 0.2% 137
2023
Q4 		$358K Sell
674
-18
-3% -$8.71K 0.2% 137
2023
Q3 		$350K Buy
692
+4
+0.6% +$2.13K 0.2% 143
2023
Q2 		$359K Sell
688
-23
-3% -$12.4K 0.2% 134
2023
Q1 		$410K Sell
711
-5
-0.7% -$2.82K 0.25% 108
2022
Q4 		$394K Buy
716
+31
+5% +$16.4K 0.25% 105
2022
Q3 		$347K Buy
685
+17
+3% +$9.51K 0.24% 112
2022
Q2 		$363K Buy
668
+2
+0.3% +$1.1K 0.24% 110
2022
Q1 		$393K Sell
666
-2
-0.3% -$1.15K 0.22% 125
2021
Q4 		$446K Buy
+668
New +$417K 0.24% 106

Other funds holding TMO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Silverlake Wealth Management's TMO Position: Q4 2024 in Review

Silverlake Wealth Management sold out of Thermo Fisher Scientific (TMO) in Q4 2024, closing a stake of 633 shares — an estimated $392K sold.

Silverlake Wealth Management first reported a position in TMO in Q4 2021 and held it in 12 quarters. The position peaked at $446K in Q4 2021. 2,623 funds tracked by Wall St. Rank hold TMO as of Q4 2024.

  • Silverlake Wealth Management reported no remaining Thermo Fisher Scientific position as of Q4 2024 after selling out during the quarter.
  • Silverlake Wealth Management sold 633 Thermo Fisher Scientific shares in Q4 2024, an estimated $392K.
  • Silverlake Wealth Management first reported a position in Thermo Fisher Scientific in Q4 2021 and held it in 12 quarters.
  • Silverlake Wealth Management's Thermo Fisher Scientific position peaked at $446K in Q4 2021.
  • 2,623 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q4 2024.

Based on Silverlake Wealth Management's 13F filing for Q4 2024, filed 27 Jan 2025.